It’s Amber Lancaster, here welcoming you to your very first issue of Bold Profits Daily.
This morning, I hopped on the phone with Paul Mampilly and Ian Dyer to discuss what caught our eye in the market this past week, and also to give you our unique investment perspective.
As a reminder, each Monday our team will send you a sneak peek of our internal investment chats, where we analyze recent market moves and forecast what’s next.
We had an invigorating Market Talk this morning, covering topics such as:
- The Russell 2000, which measures high-growth stocks, and how it’s lately been beating the S&P 500.
- Recent acquisitions in the biotech market, and how that’s a surefire indication of a market about to take off.
- Preliminary trade talks between the U.S. and China.
- The recent acquisition of Loxo Oncology Inc. (Nasdaq: LOXO) by Eli Lilly, and what that means for people who bought into this stock.
And much, much more.
Below, you’ll find a recording of this morning’s chat. Simply click on the “play” button to listen.
If you have a moment, please make sure to send us your thoughts on this new publication! Send any feedback, comments or suggestions for future content to firstname.lastname@example.org.
We’d love to hear your feedback.
All the best,
Director of Investment Research